Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma

被引:0
|
作者
Takaya Yamamoto
Noriyuki Kadoya
Ken Takeda
Haruo Matsushita
Rei Umezawa
Kiyokazu Sato
Masaki Kubozono
Kengo Ito
Yojiro Ishikawa
Maiko Kozumi
Noriyoshi Takahashi
Yu Katagiri
Hiroshi Onishi
Keiichi Jingu
机构
[1] University of Tohoku,Department of Radiation Oncology, Graduate School of Medicine
[2] Tohoku University Hospital,Radiation Technology
[3] University of Yamanashi,Department of Radiology, School of Medicine
来源
关键词
Stereotactic radiotherapy; SRT; Renal cell cancer; Renal atrophy; Renal remodeling;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
    Yamamoto, Takaya
    Kadoya, Noriyuki
    Takeda, Ken
    Matsushita, Haruo
    Umezawa, Rei
    Sato, Kiyokazu
    Kubozono, Masaki
    Ito, Kengo
    Ishikawa, Yojiro
    Kozumi, Maiko
    Takahashi, Noriyoshi
    Katagiri, Yu
    Onishi, Hiroshi
    Jingu, Keiichi
    RADIATION ONCOLOGY, 2016, 11
  • [2] Dosimetric analysis of renal toxicity after stereotactic body radiotherapy for renal cell carcinoma
    Niglas, M.
    Cheung, P.
    Swaminath, A.
    Korol, R.
    Erler, D.
    Vesprini, D.
    Chu, W.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S435 - S435
  • [3] Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes
    Glicksman, R. M.
    Cheung, P.
    Korol, R.
    Niglas, M.
    Nusrat, H.
    Erler, D.
    Vesprini, D.
    Swaminath, A.
    Davidson, M.
    Zhang, L.
    Chu, W.
    CLINICAL ONCOLOGY, 2023, 35 (01) : 20 - 28
  • [4] STEREOTACTIC BODY RADIOTHERAPY FOR RENAL CELL CARCINOMA: ONCOLOGIC AND RENAL FUNCTION OUTCOMES
    Glicksman, Rachel
    Cheung, Patrick
    Korol, Renee
    Niglas, Mark
    Nusrat, Humza
    Erler, Darby
    Vesprini, Danny
    Swaminath, Anand
    Davidson, Melanie
    Zhang, Liying
    Chu, William
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S34 - S34
  • [5] Stereotactic body radiotherapy for renal cell carcinoma: oncologic and renal function outcomes
    Glicksman, R.
    Niglas, M.
    Cheung, P.
    Korol, R.
    Erler, D.
    Vesprini, D.
    Nusrat, H.
    Davidson, M.
    Zhang, L.
    Chu, W.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S685 - S685
  • [6] The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma
    Ali, Muhammad
    Mooi, Jennifer
    Lawrentschuk, Nathan
    Mckay, Rana R.
    Hannan, Raquibul
    Lo, Simon S.
    Hall, William A.
    Siva, Shankar
    EUROPEAN UROLOGY, 2022, 82 (06) : 613 - 622
  • [7] Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma
    Kaidar-Person, Orit
    Price, Alex
    Schreiber, Eric
    Zagar, Timothy M.
    Chen, Ronald C.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (05) : E851 - E854
  • [8] Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma
    Ranck, Mark C.
    Golden, Daniel W.
    Corbin, Kimberly S.
    Hasselle, Michael D.
    Liauw, Stanley L.
    Stadler, Walter M.
    Hahn, Olwen M.
    Weichselbaum, Ralph R.
    Salama, Joseph Kamel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06): : 589 - 595
  • [9] Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) for "radioresistant" renal cell carcinoma (RCC)
    Ishiyama, Hiromichi
    Blanco, Angel I.
    Lo, Simon S.
    Butler, E. Brian
    Teh, Bin S.
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 339 - 346
  • [10] A Prospective Study of Stereotactic Body Radiotherapy in Oligometastatic Renal Cell Carcinoma
    Katipally, R. R.
    Rajeev-Kumar, G.
    Solanki, A. A.
    Arif, F.
    Eggener, S. E.
    Szmulewitz, R. Z.
    Stadler, W. M.
    Sweis, R. F.
    Pitroda, S. P.
    Liauw, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E545 - E545